Literature DB >> 23795218

The diagnosis and treatment of giant cell arteritis.

Thomas Ness1, Thorsten A Bley, Wolfgang A Schmidt, Peter Lamprecht.   

Abstract

BACKGROUND: Giant cell arteritis (GCA) is the most common systemic vasculitis in persons aged 50 and above (incidence, 3.5 per 100,000 per year). It affects cranial arteries, the aorta, and arteries elsewhere in the body, e.g., in the limbs.
METHODS: We selectively review the pertinent literature, including guidelines and recommendations from Germany and abroad.
RESULTS: The typical symptoms of new-onset GCA are bitemporal headaches, jaw claudiacation, scalp tenderness, visual disturbances, systemic symptoms such as fever and weight loss, and polymyalgia. The diagnostic assessment comprises laboratory testing (erythrocyte sedimentation rate, C-reactive protein), imaging studies (duplex sonography, high-resolution magnetic resonance imaging, positron-emission tomography), and temporal artery biopsy. The standard treatment is with corticosteroids (adverse effects: diabetes mellitus, osteoporosis, cataract, arterial hypertension). A meta-analysis of three randomized controlled trials led to a recommendation for treatment with methotrexate to lower the recurrence rate and spare steroids. Patients for whom methotrexate is contraindicated or who cannot tolerate the drug can be treated with azathioprine instead.
CONCLUSION: Giant cell arteritis, if untreated, progresses to involve the aorta and its collateral branches, leading to various complications. Late diagnosis and treatment can have serious consequences, including irreversible loss of visual function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23795218      PMCID: PMC3679627          DOI: 10.3238/arztebl.2013.0376

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  73 in total

Review 1.  Giant cell arteritis: diagnosis and management.

Authors:  M T Bhatti; H Tabandeh
Journal:  Curr Opin Ophthalmol       Date:  2001-12       Impact factor: 3.761

2.  Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis.

Authors:  Carolin Hauenstein; Matthias Reinhard; Julia Geiger; Michael Markl; Andreas Hetzel; Andras Treszl; Peter Vaith; Thorsten A Bley
Journal:  Rheumatology (Oxford)       Date:  2012-07-06       Impact factor: 7.580

3.  A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.

Authors:  P Chevalet; J H Barrier; P Pottier; G Magadur-Joly; M A Pottier; M Hamidou; B Planchon; D El Kouri; L Connan; J L Dupond; B De Wazieres; G Dien; E Duhamel; B Grosbois; P Jego; A Le Strat; J Capdeville; P Letellier; L Agron
Journal:  J Rheumatol       Date:  2000-06       Impact factor: 4.666

4.  Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis.

Authors:  Tanaz A Kermani; Jean Schmidt; Cynthia S Crowson; Steven R Ytterberg; Gene G Hunder; Eric L Matteson; Kenneth J Warrington
Journal:  Semin Arthritis Rheum       Date:  2011-11-25       Impact factor: 5.532

5.  Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.

Authors:  C M Weyand; J W Fulbright; G G Hunder; J M Evans; J J Goronzy
Journal:  Arthritis Rheum       Date:  2000-05

6.  Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients.

Authors:  M A González-Gay; C García-Porrúa; J Llorca; A H Hajeer; F Brañas; A Dababneh; C González-Louzao; E Rodriguez-Gil; P Rodríguez-Ledo; W E Ollier
Journal:  Medicine (Baltimore)       Date:  2000-09       Impact factor: 1.889

7.  The importance of skip lesions in temporal arteritis.

Authors:  D N Poller; Q van Wyk; M J Jeffrey
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

8.  Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis.

Authors:  Tanaz A Kermani; Kenneth J Warrington; Cynthia S Crowson; Steven R Ytterberg; Gene G Hunder; Sherine E Gabriel; Eric L Matteson
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

9.  Long-term corticosteroid treatment in giant cell arteritis.

Authors:  R Andersson; B E Malmvall; B A Bengtsson
Journal:  Acta Med Scand       Date:  1986

10.  2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Authors:  Bhaskar Dasgupta; Marco A Cimmino; Hilal Maradit-Kremers; Wolfgang A Schmidt; Michael Schirmer; Carlo Salvarani; Artur Bachta; Christian Dejaco; Christina Duftner; Hanne Slott Jensen; Pierre Duhaut; Gyula Poór; Novák Pál Kaposi; Peter Mandl; Peter V Balint; Zsuzsa Schmidt; Annamaria Iagnocco; Carlotta Nannini; Fabrizio Cantini; Pierluigi Macchioni; Nicolò Pipitone; Montserrat Del Amo; Georgina Espígol-Frigolé; Maria C Cid; Víctor M Martínez-Taboada; Elisabeth Nordborg; Haner Direskeneli; Sibel Zehra Aydin; Khalid Ahmed; Brian Hazleman; Barbara Silverman; Colin Pease; Richard J Wakefield; Raashid Luqmani; Andy Abril; Clement J Michet; Ralph Marcus; Neil J Gonter; Mehrdad Maz; Rickey E Carter; Cynthia S Crowson; Eric L Matteson
Journal:  Ann Rheum Dis       Date:  2012-04       Impact factor: 19.103

View more
  29 in total

1.  Spontaneous fusion between cancer cells and endothelial cells.

Authors:  K Mortensen; J Lichtenberg; P D Thomsen; L-I Larsson
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

2.  [Brain stem infarction, temporal headache, and elevated inflammatory parameters in a 74-year-old man].

Authors:  M Gehlen; M Schwarz-Eywill; N Schäfer; A Pfeiffer; H Bösenberg; A Maier; C Hinz
Journal:  Internist (Berl)       Date:  2016-06       Impact factor: 0.743

3.  Polymorphism of VEGF gene in susceptibility to chronic immune-mediated inflammatory diseases: a meta-analysis.

Authors:  Ni Wei; Zijia Chen; Zhifeng Xue; Yuelan Zhu
Journal:  Rheumatol Int       Date:  2015-05-26       Impact factor: 2.631

Review 4.  Giant cell arteritis: Current treatment and management.

Authors:  Cristina Ponte; Ana Filipa Rodrigues; Lorraine O'Neill; Raashid Ahmed Luqmani
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

5.  [Guidelines from the DOG, RG and BVA: retinal artery occlusion : November 2016 status].

Authors: 
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

Review 6.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

7.  [Ocular myositis as a rare cause of vision loss].

Authors:  J D Rollnik; H Requadt
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

8.  Practice Preferences: Temporal Artery Biopsy versus Doppler Ultrasound in the Work-Up of Giant Cell Arteritis.

Authors:  Edsel Ing; Qinyuan Alis Xu; Jean Chuo; Femida Kherani; Klara Landau
Journal:  Neuroophthalmology       Date:  2019-10-09

9.  Why a standard contrast-enhanced MRI might be useful in intracranial internal carotid artery stenosis.

Authors:  Maximilian Oeinck; Christoph Rozeik; Jens Wattchow; Stephan Meckel; Manuel Schlageter; Christel Beeskow; Matthias Reinhard
Journal:  Neuroradiol J       Date:  2016-03-17

10.  [A 58-year-old patient with temporal headache, jaw claudication and B symptoms].

Authors:  M Gehlen; M Schwarz-Eywill; N Schäfer; A Pfeiffer; J Woenkhaus; J H Bräsen
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.